BRTO /PARTO Indications and outcomes
|
|
- Ruth Benson
- 5 years ago
- Views:
Transcription
1 BRTO /PARTO Indications and outcomes Saher Sabri, MD Associate Professor of Radiology and Surgery Division of Interventional Radiology University of Virginia Health System
2 Saher Sabri, M.D. Speakers Bureau: W.L.Gore & Associates, Abbott
3 Disclosures W.L. Gore- Speaker
4 RTO Indications To treat encephalopathy GV bleed with contraindication to TIPS ( ex. Encephalopathy) Continued GV bleed after TIPS optimization ( RTO vs antegrade GV sclerosis)? Isolated GV bleed. No EVs or ascites.
5 Outcomes- Technical success 568 BRTO patients-meta-analysis Technical success rate is 91% Complete obliteration rate is 93% Partial obliteration is more common in complex varices ( 3 or more afferent veins) Takaji et al (AJR 2011) Technical and clinical failures were routinely treated with endoscopic NBCA injection Saad et al CVIR 2013
6 OUTCOMES- Rebleeding The GV rebleed rate after successful BRTO procedure was % For all types of variceal rebleed rate reached % The rate of exacerbation of existing EVs 1 year is % 2 years % 3 years % EV bleeding occurred in in % Aggressive surveillance for EVs is needed
7 Rebleeding TIPS vs BRTO - Sabri et al JVIR TIPS and 22 BRTO for GVs TIPS with embolization of afferent veins (coils and AVP) Technical success 100% TIPS and 93% BRTO Complications 4% TIPS 9% BRTO Encephalopathy 15% TIPS, 0% BRTO 1 year Rebleeding from a GV source 11% TIPS, 0% BRTO (p 0.2) 2 TIPS dysfunction and one continued bleeding despite TIPS optimization
8 Outcome Author Patients (n) Technical success (%) Rebleeding rate (%) Cho et al Hiraga et al Kitamoto et al Complete obliteration rate (%) Arai et al Ninoi et al Kanagawa et al Sabri et al Updated UVA Gown et al (PARTO)
9 PARTO (Gwon et al JVIR 2015) 73 patients ( 57 GV bleeds and 16 HE) Technical success 100% AVP II ( 8-22 mm)- 70 only had one plug Rebleeding 1/73 Complete obliteration at 3 months 98.6% All HE had resolution of symptoms and decrease in Ammonia level (p<.001) ZERO complications
10 PARTO Chang et al. (Korean J Rad) 19 pts. 95% tech success Acute complications included fever (n = 2), fever and hypotension (n = 2; one diagnosed adrenal insufficiency), and transient microscopic hematuria (n = 3) Obliteration rate 84%
11 Kim at al CVIR Jan 2016 Retrospective. 95 patients ( follow up available on 70 ) BRTO with EO in 49 patients. BRTO with STS foam in 25. PARTO in 21 Technical success was 95% (94% BRTO, 100% PARTO) Procedure time of PARTO was significantly shorter than those of other two BRTO procedures (P<0.017). More complications with EO, including one mortality from DIC.
12 Kim at al CVIR Jan cases of failure to obliterate GVs in BRTO with EO group. None with STS 4 cases of failure with PARTO. (including 2 cases of rebleeding ) At 1 YEAR 81 % obliteration rate for PARTO Statistical difference of gastric varices recurrence between two BRTO procedures and PARTO (P<0.05). Conclusion: BRTO using STS foam and PARTO are better than BRTO using EO in terms of complication or procedure time. However, PARTO showed frequent recurrence of gastric varices during the long-term follow-up compared to BRTO.
13 OUTCOMES- Portal HTN Exacerbation Development of ascites (0 44 %) hepatic hydrothorax (0 8 %) Hypertensive gastropathy (5 13 %) In our experience 4/70 ( 6%) required subsequent TIPS to treat complications of portal HTN Tanihata et al showed that 58 % of patients have > 5 mmhg increase in PSG ( 58%) and were associated with EV exacerbation
14 Effect of RTO on liver function The bilirubin rises significantly (P =.007) within days after RTO The MELD score significantly improved 3-4 months post-rto (from 14.1 to 10.7, P =.0008). Effect is transient and most patients return to baseline by 6-9 months The Child Pugh score did not change significantly (from 7.6 to 6.7, P =.063). Ascites worsened in 31% of patients Saad et al Vasc Endovasc Surgery 2013
15 RTO for Encephalopathy 65 patients reported in the literature Immediate response is % Long term improvement in HE 100% Serum Ammonia levels of 127. mmol/l decreased significantly to 28 mmol/l within 1 week after the procedure (P =.002) ( Gwon et at Radiology 2013)
16 Complications Pulmonary complications. Decrease in PaO2 and A-A gradient ( Arai et al ) PE ( Sabri et al) Venous thrombosis Partial PV or SV thrombosis up to 15% ( Cho et al) Partial renal Vein thrombosis ( 7%) Balloon rupture 8.7% ( Park et al) Stroke from air embolus( R-L shunt)
17 TIPS & RTO combination TIPS may have a protective effect on portal HTN after RTO ( 5-10% of RTO pts will require TIPS at some point) TIPS placement may prevent PV thrombosis post RTO with diminutive PVs In Encephalopathic patients, can we replace a large portosystemic shunt with a small controllable shunt (TIPS)?
18 Scenarios GV with EV or ascites and no encephalopathy: TIPS +/- GV sclerosis( RTO or antegrade) GV without EVS or ascites and encephalopathy: RTO GV with EV or ascites and encephalopathy:??tips, NBCA, banding and medical management GV without EVS or ascites and no encephalopathy: I think RTO
BRTO: Updates to Techniques
Session XIV: BRTO, PARTO and Portal Hypertension GEST2016 BRTO: Updates to Techniques Hiro Kiyosue Oita University Hospital, Japan Hiro Kiyosue, MD Royalty: Cook, Medkit Consulting Fee: Stryker Japan,
More informationEvidence-Base Management of Esophageal and Gastric Varices
Evidence-Base Management of Esophageal and Gastric Varices Rino Alvani Gani Hepatobiliary Division Department of Internal Medicine Faculty of Medicine Universitas Indonesia Cipto Mangunkusumo National
More informationContraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for:
Contraindications Absolute Relative Primary prevention variceal bleeding HCC if centrally located Active congestive heart failure Obstruction all hepatic veins Thomas D. Boyer, M.D. University of Arizona
More informationDenver Shunts vs TIPS for Ascites
Denver Shunts vs TIPS for Ascites Hooman Yarmohammadi MD Assistant Professor of Radiology Interventional Radiology & Image Guided Therapies Memorial Sloan-Kettering Cancer Center, New York, USA Hooman
More informationVARICEAL BLEEDING. Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta.
VARICEAL BLEEDING Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta Disclosures: None OUTLINE Pathophysiology of portal hypertension Splanchnic
More informationMichele Bettinelli RN CCRN Lahey Health and Medical Center
Michele Bettinelli RN CCRN Lahey Health and Medical Center Differentiate the types of varices Identify glue preparations utilized when treating gastric varices Review the process of glue administration
More informationTransjugular Intrahepatic Portosystemic Shunt Reduction for Management of Recurrent Hepatic Encephalopathy
CLINICAL IMAGES Ochsner Journal 17:311 316, 2017 Ó Academic Division of Ochsner Clinic Foundation Transjugular Intrahepatic Portosystemic Shunt Reduction for Management of Recurrent Hepatic Encephalopathy
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACLF. See Acute-on-chronic liver failure (ACLF) Acute kidney injury (AKI) in ACLF patients, 967 Acute liver failure (ALF), 957 964 causes
More informationDirect Intrahepatic Porta-Caval Shunt Technique & Tips-Tricks. Pierre GOFFETTE, MD, St-Luc University Hospital University of Leuven Brussels
Direct Intrahepatic Porta-Caval Shunt Technique & Tips-Tricks Pierre GOFFETTE, MD, St-Luc University Hospital University of Leuven Brussels Pierre Goffette, M.D. Consultant/Advisory Board: Covidien (Neuro)
More informationGI bleeding in chronic liver disease
GI bleeding in chronic liver disease Stuart McPherson Consultant Hepatologist Liver Unit, Freeman Hospital, Newcastle upon Tyne and Institute of Cellular Medicine, Newcastle University. Case 54 year old
More informationManejo Actual del Sangrado por Varices Gástricas
Manejo Actual del Sangrado por Varices Gástricas Juan Carlos Garcia-Pagán Barcelona Hepatic Hemodynamic Laboratory. Liver Unit. IMDIM. Hospital Clinic. IDIBAPS. Ciberehd. XXIV Congreso de la Asociación
More informationEndovascular Techniques for Symptomatic Portal Hypertension. Michael Meuse, M.D. Vascular and Interventional Radiology
Endovascular Techniques for Symptomatic Portal Hypertension Michael Meuse, M.D. Vascular and Interventional Radiology Objectives Review indications and contraindications for TIPS Define a treatment algorithm
More informationManagement of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide
Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals By: Dr. Kevin Dolehide Overview DX Cirrhosis and Prognosis Compensated Decompensated Complications Of Cirrhosis Management Of Complications
More informationFollow this and additional works at:
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2017 Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde
More informationGastric fundal varices with hemorrhage are
alloon-occluded Retrograde Transvenous Obliteration of Gastric Varices review of the anatomy, technique, and outcomes. Y SHER S. SRI, MD; ULKU C. TUR, MD; WEL E.. SD, MD; UH WHN PRK, MD; ND JOHN F. NGLE,
More informationTranjugular Intrahepatic Portosystemic Shunt
Tranjugular Intrahepatic Portosystemic Shunt Christopher Selhorst July 25, 2005 BIDMC Radiology Overview Portal Hypertension Indications, Contraindications The Procedure Case Review Complications Outcomes
More informationBarbara Rus Gadžijev Peter Popovič Klinični inštitut za radiologijo UKC Ljubljana
STROKOVNI SESTANEK ZDRUŽENJA HEMATOLOGOV SLOVENIJE IN ZDRUŽENJA ZA TRANSFUZIJSKO MEDICINO, Terme Zreče, 17.-18.4.2015 Barbara Rus Gadžijev Peter Popovič Klinični inštitut za radiologijo UKC Ljubljana goals,
More informationTransjugular Intrahepatic
Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Clinical and Procedural Review Mark R. Werley, M.D. and John Briguglio, M.D. Lancaster Radiology Associates, Ltd. INTRODUCTION This article reviews
More informationBleeding Gastric Varices Obliteration with Balloonoccluded Retrograde Transvenous Obliteration Using Sodium Tetradecyl Sulfate Foam
CLINICAL STUDY Bleeding Gastric Varices Obliteration with Balloonoccluded Retrograde Transvenous Obliteration Using Sodium Tetradecyl Sulfate Foam Saher S. Sabri, MD, Warren Swee, MD, Ulku C. Turba, MD,
More informationACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
ACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis Guadalupe Garcia-Tsao, M.D., 1 Arun J. Sanyal, M.D., 2 Norman D. Grace,
More informationVirtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12:
Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12: 805-809. CLINICAL PEARL Indications for Use of TIPS in Treating Portal Hypertension Elizabeth C. Verna,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute variceal bleeding management of, 251 262 balloon tamponade of esophagus in, 257 258 endoscopic therapies in, 255 257. See also Endoscopy,
More informationAASLD PRACTICE GUIDELINE. The Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension. Preamble.
AASLD PRACTICE GUIDELINE The Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension Thomas D. Boyer 1 and Ziv J. Haskal 2 Preamble The recommendations in this article
More informationVariceal bleeding. Mainz,
Variceal bleeding Mainz, 21.09.2008 Risk of complications 5 years 10 years Ascites 10 % 25 % HCC 10 % 25 % Bleeding < 5 % 5-10 % Enceph. < 5 % < 5 % Typical situation : Mortality 10 % to 40 % Sequence
More informationControversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate
Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate Patrick Northup, MD, FAASLD, FACG Medical Director, Liver Transplantation University of Virginia
More informationManagement of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University
Management of Cirrhotic Complications Uncontrolled Ascites Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University Topic Definition, pathogenesis Current therapeutic options Experimental treatments
More informationMANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT
MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT Sherona Bau, ACNP The Pfleger Liver Institute 200 UCLA Medical Plaza, Suite 214 Los Angeles, CA 90095 September 30, 2017 I
More informationPORTAL HYPERTENSION An Introduction to the Culprit of Many Liver Failure Complications
PORTAL HYPERTENSION An Introduction to the Culprit of Many Liver Failure Complications Edy G. Trujillo, RN, MSN, ACNP-BC Liver Transplant RRUCLA Medical Center July 31, 2018 What Do We All Look Forward
More informationTreating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC
Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC mino.mitri@ubc.ca No Conflict of Interest 157 patients 157 patients 6 transplanted Criteria Liver
More informationInterventional Treatment VTE: Radiologic Approach
Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea Introduction Incidence High incidence: 250,000-1,000,000/year
More informationSclerosing Agents: Tips & Tricks Session: Liquid Embolics
Sclerosing Agents: Tips & Tricks Session: Liquid Embolics Jeffrey S. Pollak, M.D. Robert I. White, Jr., M.D. Professor of Interventional Radiology Yale University School of Medicine Department of Radiology
More informationMinimally Invasive Treatment Options for Renal Artery FMD
Minimally Invasive Treatment Options for Renal Artery FMD FMDSA Meeting 2016 Alan H. Matsumoto, M.D., FSIR, FACR, FAHA Professor and Chair Department of Radiology & Medical Imaging University of Virginia
More informationA A U
PVD Venous AUC Rating Sheet 2nd Round 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Median I NI MADM Rating Agree Disagree Upper Extremity Venous Evaluation Table 1. Venous Duplex of the Upper Extremities for Patency
More informationManagement of Cirrhosis Related Complications
Management of Cirrhosis Related Complications Ke-Qin Hu, MD, FAASLD Professor of Clinical Medicine Director of Hepatology University of California, Irvine Disclosure I have no disclosure related to this
More informationAscites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology
Ascites Management Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Disclosure 1. The speaker Atif Zaman, MD MPH have no relevant
More informationHepatopulmonary Syndrome: An Update
Hepatopulmonary Syndrome: An Update Michael J. Krowka MD Professor of Medicine Division of Pulmonary and Critical Care Division of Gastroenterology and Hepatology Mayo Clinic Falk Liver Week October 11,
More informationUpdate in abdominal Surgery in cirrhotic patients
Update in abdominal Surgery in cirrhotic patients Safi Dokmak HBP department and liver transplantation Beaujon Hospital, Clichy, France Cairo, 5 April 2016 Cirrhosis Prevalence in France (1%)* Patients
More informationLiver Transplantation Evaluation: Objectives
Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation
More informationApproaches to type II Endoleaks: Transcaval, transarterial, translumbar. Saher Sabri,MD University of Virginia
Approaches to type II Endoleaks: Transcaval, transarterial, translumbar Saher Sabri,MD University of Virginia Saher Sabri, M.D. Speakers Bureau: W.L.Gore & Associates, Abbott Type 2 Endoleaks after EVAR
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Accelerated intravascular coagulation and fibrinolysis (AICF) in liver disease, 390 391 Acid suppression in liver disease, 403 404 ACLF.
More informationSteps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV
Overview of Liver Disease Associated With HCV Marion G. Peters, MD John V. Carbone, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco San Francisco,
More informationPrimary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation
Primary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation Siwaporn Chainuvati, MD Faculty of Medicine Siriraj Hospital Outline Natural history of esophageal varices Which
More informationBETA-BLOCKERS IN CIRRHOSIS.PRO.
BETA-BLOCKERS IN CIRRHOSIS.PRO. Angela Puente Sánchez. MD PhD Hepatology Unit. Gastroenterology department Marques de Valdecilla University Hospital. Santander INTRODUCTION. Natural history of cirrhosis
More informationTitle: Cholestasis after TIPS placement in a patient with primary sclerosing cholangitis: an uncommon complication
Title: Cholestasis after TIPS placement in a patient with primary sclerosing cholangitis: an uncommon complication Authors: Alejandro Salagre García, Carolina Muñoz Codoceo, Elena Gómez Domínguez, Inmaculada
More informationGastrointestinal System: Accessory Organ Disorders
Gastrointestinal System: Accessory Organ Disorders Mary DeLetter, PhD, RN Associate Professor Dept. of Baccalaureate and Graduate Nursing Eastern Kentucky University Disorders of Accessory Organs Portal
More informationPortal Venous Interventions: State of the Art 1
This copy is for personal use only. To order printed copies, contact reprints@rsna.org David C. Madoff, MD Ron C. Gaba, MD Charles N. Weber, MD Timothy W. I. Clark, MD Wael E. Saad, MD Online SA-CME See
More informationHepatocellular carcinoma: Intra-arterial treatments
Hepatocellular carcinoma: Intra-arterial treatments Irene Bargellini U.O. Radiologia Interventistica Azienda Ospedaliero Universitaria Pisana IRENE BARGELLINI,MD UO RADIOLOGIA INTERVENTISTICA, AZIENDA
More informationDiagnostic Procedures. Measurement of Hepatic venous pressure in management of cirrhosis. Clinician s opinion
5 th AISF Post-Meeting Course Diagnostic and Therapeutic Invasive Procedures in Hepatology Rome, February 25 th Diagnostic Procedures Measurement of Hepatic venous pressure in management of cirrhosis Clinician
More informationGastro-Intestinal Bleeding- Interventional Radiology turning off the tap. Simon McPherson, Vascular Interventional Radiologist, Leeds
Gastro-Intestinal Bleeding- Interventional Radiology turning off the tap Simon McPherson, Vascular Interventional Radiologist, Leeds Scale UK 100,000 /year Commonest Vascular IR on-call 75% UGIB 65% NVUGIB
More informationPortogram shows opacification of gastroesophageal varices.
Portogram shows opacification of gastroesophageal varices. http://clinicalgate.com/radiologic-hepatobiliary-interventions/ courtesyhttp://emedicine.medscape.com/article/372708-overview DR.Thulfiqar Baiae
More informationThe Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist. K V Speeg, MD, PhD UT Health San Antonio
The Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist K V Speeg, MD, PhD UT Health San Antonio Objectives Review staging of liver disease Review consequences of end-stage
More informationTIPS. D Patch Royal Free Hospital London UK
TIPS D Patch Royal Free Hospital London UK TIPS Technique Ascites Budd Chiari Variceal Bleeding Historical Experimental Development 1967 Piccone Shunt between recanalized umbilical vein and saphenous
More informationPORTAL HYPERTENSION. Tianjin Medical University LIU JIAN
PORTAL HYPERTENSION Tianjin Medical University LIU JIAN DEFINITION Portal hypertension is present if portal venous pressure exceeds 10mmHg (1.3kPa). Normal portal venous pressure is 5 10mmHg (0.7 1.3kPa),
More informationConflict of interest disclosures. Complications of end stage liver disease. None. The many complications of Cirrhosis. Portal Hypertension.
Complications of end stage liver disease Conflict of interest disclosures None Amir Qamar, MD Instructor of Medicine Brigham and Women s s Hospital Harvard Medical School Boston, MA 02115 The many complications
More informationSIRTEX Lunch Symposium, Cebu, 23 Nov Dr. Stephen L. Chan Department of Clinical Oncology The Chinese University of Hong Kong
SIRTEX Lunch Symposium, Cebu, 23 Nov 2013 Dr. Stephen L. Chan Department of Clinical Oncology The Chinese University of Hong Kong I will not talk on Mechanism of SIRT Data on efficacy of SIRT Epidemiology
More informationFaculty Disclosure. Objectives. Cirrhosis Management for the Family Physician 18/11/2014
Cirrhosis Management for the Family Physician Mang Ma, MD, FRCP Professor University of Alberta Faculty: Mang Ma Faculty Disclosure Relationships with commercial interests: Advisory Board: Merck, Gilead
More informationTransjugular Intrahepatic Portosystemic Shunt Flow Reduction with Adjustable Polytetrafluoroethylene-covered Balloon-expandable Stents
Transjugular Intrahepatic Portosystemic Shunt Flow Reduction with Adjustable Polytetrafluoroethylene-covered Balloon-expandable Stents Ghazwan Kroma, MD, Jorge Lopera, MD, PhD, Marco Cura, MD, Rajeev Suri,
More informationUse of transjugular intrahepatic portosystemic shunt in liver disease
Vol. XVIII No. 3 JOURNAL OF VASCULAR NURSING PAGE 83 Use of transjugular intrahepatic portosystemic shunt in liver disease Patricia Ann Radovich, RN, MSN, CCRN, FCCM Persons with cirrhosis have many complications.
More informationDefinition: fibrosis and nodular regeneration resulting from hepatocellular injury
Cirrhosis Understanding the liver: Patterns of LFT Abnormalities - Hepatocellular/Transaminitis: o Ratio of AST: ALT >2:1 ETOH (keep in mind AST is also produced by red cells, heart muscle) o If Aminotransferases
More informationLIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.
LIVER CIRRHOSIS William Sanchez, M.D. & Jayant A. Talwalkar, M.D., M.P.H. Advanced Liver Disease Study Group Miles and Shirley Fiterman Center for Digestive Diseases Mayo College of Medicine Rochester,
More informationThe Leeds Teaching Hospitals NHS Trust Transjugular Intrahepatic Portosystemic Shunt (TIPS)
n The Leeds Teaching Hospitals NHS Trust Transjugular Intrahepatic Portosystemic Shunt (TIPS) Information for patients Your liver doctor has recommended that you have a Transjugular Intrahepatic Portosystemic
More informationEditorial Process: Submission:07/25/2018 Acceptance:10/19/2018
RESEARCH ARTICLE Editorial Process: Submission:07/25/2018 Acceptance:10/19/2018 Clinical Outcome and Predictive Factors of Variceal Bleeding in Patients with Hepatocellular Carcinoma in Thailand Jitrapa
More informationWithin-patient temporal variance in MELD score and impact on survival prediction after TIPS creation
Survival prediction after TIPS creation., 2013; 12 (5): 797-802 ORIGINAL ARTICLE September-October, Vol. 12 No.5, 2013: 797-802 797 Within-patient temporal variance in MELD score and impact on survival
More informationTransjugular intrahepatic portosystemic shunt in the treatment of symptomatic portal hypertension
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1338 Transjugular intrahepatic portosystemic shunt in the treatment of symptomatic portal hypertension KERSTIN ROSENQVIST
More informationSupplemental Appendix. 1. Protocol Definition of Sustained Virologic Response. A patient has a sustained virologic response if:
Supplemental Appendix 1. Protocol Definition of Sustained Virologic Response A patient has a sustained virologic response if: 1. The patient is a responder at the end of treatment and all subsequent planned
More informationClinical Study Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
Gastroenterology Research and Practice, Article ID 659726, 8 pages http://dx.doi.org/10.1155/2014/659726 Clinical Study Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension
More informationEmbolization in Polycystic Liver and Kidney Disease
Embolization in Polycystic Liver and Kidney Disease Francois Cornelis, MD, PhD Radiology Department Bordeaux, France francois.cornelis@chu-bordeaux.fr Francois Cornelis, MD, PhD No relevant financial relationship
More informationEsophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph
Esophageal Varices Beta-Blockers or Band Ligation Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph Esophageal Varices Beta-Blockers or Band Ligation? Risk of esophageal variceal
More informationCreation of an Arteriovenous Fistula to Treat Hypertension
Creation of an Arteriovenous Fistula to Treat Hypertension Horst Sievert, Ilona Hofmann, Laura Vaskelyte, Sameer Gafoor, Stefan Bertog, Predrag Matić, Markus Reinartz, Bojan Jovanovic, Kolja Sievert CardioVascular
More informationSurgical Rescue of Surgical Failures
HPB Surgery, 1999, Vol. 11, pp. 151-155 Reprints available directly from the publisher Photocopying permitted by license only (C) 1999 OPA (Overseas Publishers Association) N.V. Published by license under
More informationPractical Approach to Endoscopic Management for Bleeding Gastric Varices
Review Article http://dx.doi.org/10.3348/kjr.2012.13.s1.s40 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2012;13(S1):S40-S44 Practical Approach to Endoscopic Management for Bleeding Gastric Varices
More informationLuis S. Marsano, MD March 2013
Portal HTN: Variceal Bleed, Portal Gastropathy, Hepatopulmonary Syndrome, Porto Pulmonary Hypertension, Cardiomyopathy, and Acute on Chronic Liver Failure Luis S. Marsano, MD March 2013 Variceal Hemorrhage
More informationNYU School of Medicine Department of Radiology Rotation-Specific House Staff Evaluation
Vascular & Interventional Radiology Rotation 1 Core competency in vascular and interventional radiology during the first resident rotation consists of clinical objectives, technical objectives and image
More informationEDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:1187 1191 EDUCATION PRACTICE Management of Refractory Ascites ANDRÉS CÁRDENAS and PERE GINÈS Liver Unit, Institute of Digestive Diseases, Hospital Clínic,
More informationRG Volume 33 Number 5 Kirby et al 1497
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. RG Volume 33 Number
More informationFactors Predicting Survival after Transjugular Intrahepatic Portosystemic Shunt Creation: 15 Years Experience from a Single Tertiary Medical Center
Factors Predicting Survival after Transjugular Intrahepatic Portosystemic Shunt Creation: 15 Years Experience from a Single Tertiary Medical Center Jen-Jung Pan, MD, PhD, Chaoru Chen, PhD, James G. Caridi,
More informationPreoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal surgery
REVIEW ARTICLE Annals of Gastroenterology (2017) 31, 330-337 Preoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal Deepanshu Jain a, Ejaz Mahmood
More informationLiver failure &portal hypertension
Liver failure &portal hypertension Objectives: by the end of this lecture each student should be able to : Diagnose liver failure (acute or chronic) List the causes of acute liver failure Diagnose and
More informationIntrahepatic Portosystemic Venous Shunt: Successful Embolization Using the Amplatzer Vascular Plug II
Case Report http://dx.doi.org/10.3348/kjr.2012.13.6.827 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2012;13(6):827-831 Intrahepatic Portosystemic Venous Shunt: Successful Embolization Using the Amplatzer
More informationRisk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis
Original Article Page 1 of 9 Risk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis Rui Sun*, Xingshun Qi* #, Deli Zou, Xiaodong Shao, Hongyu Li, Xiaozhong
More informationNoncirrhotic Portal Hypertension: Imaging, Hemodynamics, and Endovascular Therapy
REVIEW Noncirrhotic Portal Hypertension: Imaging, Hemodynamics, and Endovascular Therapy Venkatesh P. Krishnasamy, M.D.,* Michael J. Hagar, M.D., Albert K. Chun, M.D., M.B.A., and Elliot Levy, M.D. Patients
More informationHepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center
Hepatocellular Carcinoma: A major global health problem David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center Hepatocellular Carcinoma WORLDWIDE The #2 Cancer Killer Overall cancer
More informationHepatocellular Carcinoma: Diagnosis and Management
Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm
More informationDRAFT. Angiography: Transjugular Intrahepatic Portosystemic Shunt (TIPS) What to expect. What is a transjugular intrahepatic portosystemic shunt?
UW MEDICINE PATIENT EDUCATION Angiography: Transjugular Intrahepatic Portosystemic Shunt (TIPS) What to expect This handout explains a transjugular intrahepatic portosystemic shunt and what to expect when
More informationAssessment of Liver Function: Implications for HCC Treatment
Assessment of Liver Function: Implications for HCC Treatment A/P Dan Yock Young MBBS, PhD, MRCP, MMed. FAMS Chair, University Medicine Cluster. NUHS Head, Department of Medicine, National University of
More informationOriginal Article INTRODUCTION. pissn eissn X
pissn 2287-2728 eissn 2287-285X Original Article Clinical and Molecular Hepatology 2016;22:466-476 Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active
More informationClinical Outcomes and Prognostic Factors Associated with Survival after Balloon-occluded Retrograde Transvenous Obliteration of Gastric Varices
Showa Univ J Med Sci 23 2, 89 99, June 2011 Original Clinical Outcomes and Prognostic Factors Associated with Survival after Balloon-occluded Retrograde Transvenous Obliteration of Gastric Varices Shojiro
More informationENCORE-PH Top-line Results
ENCORE-PH Top-line Results Striving to improve human health December 5, 2018 NASDAQ CNAT Forward-looking Statements This presentation contains forward-looking statements. All statements other than statements
More informationLife After SVR for Cirrhotic HCV
Life After SVR for Cirrhotic HCV KIM NEWNHAM MN, NP CIRRHOSIS CARE CLINIC UNIVERSITY OF ALBERTA Objectives To review the benefits of HCV clearance in cirrhotic patients To review some of the emerging data
More informationINSTRUCTIONS FOR USE FOR: English
INSTRUCTIONS FOR USE FOR: en English dk TABLE OF CONTENTS DESCRIPTION...1 INTENDED USE/INDICATIONS FOR USE...2 CONTRAINDICATIONS...2 WARNINGS...2 PRECAUTIONS...3 MAGNETIC RESONANCE IMAGING (MRI)...3 ADVERSE
More informationLearning Objectives. After attending this presentation, participants will be able to:
Learning Objectives After attending this presentation, participants will be able to: Describe HCV in 2015 Describe how to diagnose advanced liver disease and cirrhosis Identify the clinical presentation
More informationfollowing the last documented transfusion; thereafter, evaluate the residual impairment(s).
Adult Listings 5.01 Category of Impairments, Digestive System 5.02 Gastrointestinal hemorrhaging from any cause, requiring blood transfusion (with or without hospitalization) of at least 2 units of blood
More informationThe role of TIPS in the management of liver transplant candidates
Original Article The role of TIPS in the management of liver transplant candidates United European Gastroenterology Journal 217, Vol. 5(8) 11 117! Author(s) 217 Reprints and permissions: sagepub.co.uk/journalspermissions.nav
More informationPreliminary study of the permeability and safety of covered stents-grafts in pediatric TIPS
Preliminary study of the permeability and safety of covered stents-grafts in pediatric TIPS Poster No.: C-0354 Congress: ECR 2013 Type: Scientific Exhibit Authors: A. Bueno Palomino, L. Zurera Tendero,
More informationRisk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients
Oregon Health & Science University OHSU Digital Commons Scholar Archive 9-2014 Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients
More informationHypoxemia post Liver-Transplantation for Hepatopulmonary Syndrome
! Hypoxemia post Liver-Transplantation for Hepatopulmonary Syndrome HS Jeffrey Man University Health Network and Mount Sinai Hospital Keenan Research Centre at the Li Ka Shing Knowledge Institute, St.
More informationAN UNUSUAL CAUSE OF HEPATIC ENCEPHALOPATHY
Originally Posted: June 01, 2014 AN UNUSUAL CAUSE OF HEPATIC ENCEPHALOPATHY Resident(s): Rajesh Bhavsar, MD Program/Dept(s): Montefiore Medical Center, Albert Einstein College of Medicine CHIEF COMPLAINT
More information